2021-2022: A year in review

As the ISSCR turns 20 this year, it is humbling to reflect on and the many contributions of our Society. We can celebrate the curiosity, ingenuity, and persistence of our members that have yielded significant advances in stem cell research and regenerative medicine since those early days. From our improved understanding of key stem cell niches, the Nobel Prize-winning development of induced pluripotent stem cells to the first in human treatments for diseases including epidermolysis bullosa and type 1 diabetes, the potential of stem cells becomes more and more evident with each year. The ISSCR hosted its first annual meeting in Washington, DC in 2003, launched the first version of what is now called lished the first issue of Stem Cell Reports in 2013, established a policy and advocacy program in 2015, and hosted our first international symposium in 2016. All these initiatives placed our members??? needs front and center. Adapting to our rapidly growing field and leading the international